DE69814072D1 - Caspases und apoptosis - Google Patents

Caspases und apoptosis

Info

Publication number
DE69814072D1
DE69814072D1 DE69814072T DE69814072T DE69814072D1 DE 69814072 D1 DE69814072 D1 DE 69814072D1 DE 69814072 T DE69814072 T DE 69814072T DE 69814072 T DE69814072 T DE 69814072T DE 69814072 D1 DE69814072 D1 DE 69814072D1
Authority
DE
Germany
Prior art keywords
caspases
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69814072T
Other languages
English (en)
Other versions
DE69814072T2 (de
Inventor
Dennis Lee
A Long
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of DE69814072D1 publication Critical patent/DE69814072D1/de
Application granted granted Critical
Publication of DE69814072T2 publication Critical patent/DE69814072T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
DE69814072T 1997-07-30 1998-07-30 Caspases und apoptosis Expired - Fee Related DE69814072T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5424997P 1997-07-30 1997-07-30
US54249P 1997-07-30
PCT/US1998/015909 WO1999006042A1 (en) 1997-07-30 1998-07-30 Caspases and apoptosis

Publications (2)

Publication Number Publication Date
DE69814072D1 true DE69814072D1 (de) 2003-06-05
DE69814072T2 DE69814072T2 (de) 2004-03-11

Family

ID=21989752

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69814072T Expired - Fee Related DE69814072T2 (de) 1997-07-30 1998-07-30 Caspases und apoptosis

Country Status (13)

Country Link
US (1) US6214858B1 (de)
EP (1) EP0988035B1 (de)
JP (1) JP2001511449A (de)
AR (1) AR016551A1 (de)
AT (1) ATE238787T1 (de)
AU (1) AU8762898A (de)
CA (1) CA2298668A1 (de)
CO (1) CO4970744A1 (de)
DE (1) DE69814072T2 (de)
ES (1) ES2198739T3 (de)
IL (1) IL132771A0 (de)
WO (1) WO1999006042A1 (de)
ZA (1) ZA986761B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
BR0108193A (pt) * 2000-02-10 2003-02-25 Wyeth Corp Processo para tratamento ou inibição de dano celular ou morte celular
US9219708B2 (en) * 2001-03-22 2015-12-22 DialwareInc. Method and system for remotely authenticating identification devices
MXPA04000134A (es) 2001-06-26 2005-06-06 Abgenix Inc Anticuerpos para ligandos de osteoprotegerina.
WO2003088917A2 (en) * 2002-04-19 2003-10-30 Vertex Pharmaceuticals Incorporated Regulation of tnf-alpha
EP1545608A4 (de) 2002-06-28 2006-09-13 Centocor Inc Ch1-deletierte säugetier-mimetikörper, zusammensetzungen, verfahren und anwendungen
BRPI0314038B8 (pt) 2002-09-06 2021-05-25 Amgen Inc anticorpo humano isolado, molécula de ácido nucleico isolada, vetor, uso de um anticorpo, e, composição farmacêutica
WO2005007192A2 (en) * 2003-06-06 2005-01-27 Fibrogen, Inc. Cytoprotection through the use of hif hydroxylase inhibitors
CA2542412A1 (en) * 2003-10-21 2005-05-06 Aga Ab Use of xenon for the prevention of programmed cell death
US7256198B2 (en) 2004-02-18 2007-08-14 Wyeth Pyrimidoindolones and methods for using same
AU2005228950B2 (en) * 2004-03-23 2012-02-02 Genentech, Inc. Azabicyclo-octane inhibitors of IAP
RU2311180C2 (ru) * 2005-04-28 2007-11-27 Галина Викторовна Сукоян Средство для предотвращения прогрессирования апоптотических и купирования некротических изменений в тканях организма
EP2435073A4 (de) * 2009-05-29 2013-03-27 Xoma Technology Ltd Zur kardiovaskulären behandlung erfolgende verwendung von il-1-beta-antikörpern und bindungsfragmenten davon
WO2011137089A1 (en) * 2010-04-29 2011-11-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Activators of human pyruvate kinase
EP3836954A1 (de) 2018-08-13 2021-06-23 Iltoo Pharma Kombination von interleukin-2 mit einem interleukin-1-inhibitor, konjugate und therapeutische verwendungen davon
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164404A (en) * 1991-03-15 1992-11-17 Neurosearch A/S Hydrazone derivatives and their use
EP0533226A3 (en) * 1991-08-16 1993-08-18 Merck & Co. Inc. Novel chromophore containing compounds
US5763220A (en) * 1996-12-12 1998-06-09 Incyte Pharmaceuticals, Inc. Human apoptosis-related calcium-binding protein
AR016384A1 (es) * 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.

Also Published As

Publication number Publication date
US6214858B1 (en) 2001-04-10
ZA986761B (en) 1999-02-01
DE69814072T2 (de) 2004-03-11
JP2001511449A (ja) 2001-08-14
AR016551A1 (es) 2001-07-25
EP0988035B1 (de) 2003-05-02
CA2298668A1 (en) 1999-02-11
EP0988035A4 (de) 2001-09-19
ES2198739T3 (es) 2004-02-01
AU8762898A (en) 1999-02-22
EP0988035A1 (de) 2000-03-29
CO4970744A1 (es) 2000-11-07
IL132771A0 (en) 2001-03-19
WO1999006042A1 (en) 1999-02-11
ATE238787T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
DE69738197D1 (de) Azolotriazine und pyrimidine
DE69828963D1 (de) Wirstoffabgabe und gentherapiesystem
DE69826825D1 (de) Schaltungsanordnung und zugehörige signalleuchte
DE19983771T1 (de) Elektrochrome Gebilde und Strukturen
DE69924002D1 (de) Kompressions-abgestimmtes bragggitter und kompressions-abgestimmter laser
DE69834616D1 (de) Tastsinnempfindlicher detektor und signalisierungseinheit
DE69819812D1 (de) Fahrradschalter und Gehäuse dafür
PT946323E (pt) Pos de niobio e condensadores eletroliticos de niobio
DE69738784D1 (de) Konstruktionselemente
NO20000125D0 (no) Tiadiazolyl- og oksadiazolylfenyloksazolidinon- antibakterielle midler
DE69831750D1 (de) Biozide und biozide tücher
DE69833304D1 (de) Gesamt-optische Zeitdemultiplex-Schaltung und gesamtoptische TDM-WDM Konversionsschaltung
DE59804804D1 (de) Optisches schaltelement und schaltanordnung
ATE238787T1 (de) Caspases und apoptosis
ZA986760B (en) Caspases and apoptosis
DE69830132D1 (de) Ausgedehnte und transparente Beleuchtungseinrichtung
DE69833414D1 (de) Modulator und Demodulator
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
EP1087663A4 (de) Caspasen und apoptose
DE69730545D1 (de) Arithmetische Einheit
NO990264L (no) Azolotriaziner og -pyrimidiner
PT958285E (pt) Benzo¬e|isoindois e benzo¬h|isoquinolinas triciclicos
DE69905027D1 (de) N-sulphonyl und n-sulphinyl phenylglycinamide
EP1242081A4 (de) Caspases und apoptose
DE69842206D1 (de) Echounterdrücker und echounterdrückungsverfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee